Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26255,119,1.29 [0.94-1.77],0.1126479735068239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",26989,200,1.14 [0.89-1.47],0.289889672343514
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26710,1319,1.11 [1.01-1.22],0.0389586321779299
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Candidiasis,27016,466,1.06 [0.90-1.25],0.4997018044051873
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26170,3457,1.14 [1.07-1.21],2.384764463898036e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26399,2852,1.11 [1.03-1.18],0.003386489468125
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,26734,1366,1.16 [1.06-1.28],0.0018004905080841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,26913,91,1.28 [0.89-1.83],0.1768271051809352
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25172,805,1.21 [1.07-1.37],0.0023431974183335
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24355,947,1.19 [1.06-1.33],0.0029203633097998
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24365,254,1.17 [0.93-1.45],0.1737285506252388
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18968,1663,1.16 [1.06-1.26],0.00094293611042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24149,369,1.24 [1.04-1.49],0.019632110181704
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26953,1585,1.15 [1.06-1.26],0.0016288404640183
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,27078,528,1.08 [0.92-1.26],0.3437422017277236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26327,936,1.12 [0.99-1.25],0.0611506835265615
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27023,887,1.21 [1.07-1.36],0.0016576243561742
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25568,200,1.15 [0.90-1.48],0.268410818660477
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27138,47,1.30 [0.79-2.13],0.2970054791184829
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26915,779,1.21 [1.06-1.37],0.0032275274729003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,26902,80,1.17 [0.79-1.73],0.4387010258446289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27040,190,1.34 [1.05-1.71],0.0197605954021284
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27022,172,1.26 [0.97-1.64],0.0825394541018543
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25735,344,1.16 [0.96-1.40],0.1338277296302003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,25650,259,1.05 [0.84-1.31],0.6926583578633111
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25494,126,1.55 [1.17-2.05],0.002416225610932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27113,34,1.07 [0.57-1.99],0.8328383468196972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27065,153,1.01 [0.76-1.36],0.9273249213172636
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral warts,26959,47,0.97 [0.57-1.66],0.9234412314008638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],26985,73,1.06 [0.70-1.61],0.7902996246346832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,26869,240,1.01 [0.80-1.28],0.941060398036578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27034,70,1.13 [0.74-1.72],0.580248471208726
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27033,70,1.29 [0.86-1.95],0.2203615859832077
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26853,1207,0.98 [0.88-1.09],0.7101640125795542
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of meninges,27110,78,1.40 [0.96-2.04],0.0783319239003796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27073,63,1.21 [0.78-1.86],0.3904832299596111
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27104,132,0.99 [0.72-1.37],0.9751604538785776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of ovary,27056,171,0.94 [0.71-1.24],0.6628555365260089
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27116,271,0.88 [0.70-1.11],0.2748475655747673
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Caecum,27122,248,0.90 [0.72-1.14],0.4050599413634971
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27050,60,1.04 [0.65-1.65],0.8849796429009344
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Descending colon,27121,154,0.65 [0.47-0.89],0.0069175199884683
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,27083,279,1.10 [0.89-1.36],0.3679942193115085
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27033,491,0.96 [0.81-1.13],0.6138999562143128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27118,295,0.82 [0.66-1.02],0.078130174280958
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Carcinoma in situ of breast,22008,134,0.58 [0.41-0.81],0.0017696883721028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22099,164,0.78 [0.58-1.05],0.0973622699458159
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22075,32,2.34 [1.56-3.51],3.827657703925971e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22110,67,1.51 [1.02-2.23],0.0414594324893155
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27071,135,0.81 [0.59-1.13],0.2150888495705371
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",27072,134,0.83 [0.60-1.15],0.2590325727257783
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,26159,574,0.91 [0.78-1.07],0.2580101880707454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lung cancer and mesothelioma,19472,310,1.01 [0.82-1.25],0.9226101117346914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,22081,38,2.17 [1.43-3.29],0.0002539429258372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22219,176,0.99 [0.76-1.31],0.9639775484142876
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22152,109,0.84 [0.58-1.20],0.3422444985950717
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22228,185,0.99 [0.76-1.29],0.9416906113024004
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22112,69,1.21 [0.80-1.84],0.3664890067997923
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22113,70,1.58 [1.08-2.30],0.0186390303356878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22096,53,1.20 [0.74-1.93],0.4630241139275549
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22182,139,0.95 [0.70-1.30],0.7685545976932225
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22145,102,0.97 [0.68-1.40],0.8791937633616909
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22121,78,0.89 [0.58-1.36],0.5875184414734216
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22085,42,1.43 [0.87-2.37],0.1590300660371472
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22124,81,0.96 [0.64-1.44],0.8294387057364215
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,26882,227,1.26 [1.00-1.58],0.0482944670821081
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of trunk,27093,78,1.38 [0.94-2.00],0.0971010226633364
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanoma in situ,22078,88,1.03 [0.70-1.51],0.8785424837996105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22122,79,1.37 [0.94-1.99],0.1059940310468812
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22194,151,1.54 [1.19-2.00],0.0009764036206153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22272,229,0.91 [0.71-1.17],0.4656144584966148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22135,92,1.75 [1.28-2.40],0.0004294081500788
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,26913,163,1.07 [0.81-1.41],0.6367268689513039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22966,923,1.03 [0.91-1.16],0.6569609596799022
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23005,962,1.03 [0.91-1.15],0.6708340892692107
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26834,362,1.13 [0.94-1.36],0.1961246723868438
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25145,105,1.45 [1.05-2.01],0.023606602429371
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26541,69,1.70 [1.17-2.47],0.0057480075342299
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26135,2935,1.17 [1.10-1.25],2.044669596078658e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,25510,36,0.72 [0.38-1.38],0.324020748334015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,26739,48,2.19 [1.52-3.16],2.760805597670145e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26557,1517,1.18 [1.08-1.29],0.0003821294510021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26557,1517,1.18 [1.08-1.29],0.0003821294510021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25108,68,1.39 [0.93-2.09],0.1081306923472202
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26733,1259,1.23 [1.12-1.36],3.0207780471855435e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,26812,121,0.90 [0.64-1.26],0.5276726743028997
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,26523,51,1.09 [0.66-1.80],0.7286138749078813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,26529,57,1.08 [0.67-1.75],0.7452675110057387
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,26922,231,1.22 [0.97-1.53],0.0861196642094517
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27023,60,1.55 [1.02-2.34],0.0379828225661553
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",26884,193,0.94 [0.72-1.22],0.6427531856346718
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,25605,131,1.38 [1.03-1.86],0.0291977490678132
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21810,248,1.09 [0.87-1.37],0.4472760198485019
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25721,67,1.37 [0.91-2.08],0.1326538071407642
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25718,64,1.92 [1.25-2.95],0.0029058869991949
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,21615,53,1.49 [0.97-2.29],0.0661732901811914
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,24882,69,1.28 [0.84-1.95],0.2436882295099489
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,24535,247,1.02 [0.81-1.29],0.8596584925138768
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",26699,510,0.93 [0.79-1.10],0.4132736909632727
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,26475,286,0.96 [0.77-1.19],0.6907770740495061
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26275,86,1.22 [0.85-1.77],0.2841845786187212
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,26741,1928,1.07 [0.99-1.16],0.1079864123955369
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,23994,1878,1.09 [1.00-1.18],0.042059677201069
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",21621,59,1.21 [0.77-1.90],0.4111416077832175
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24066,118,1.00 [0.72-1.40],0.9827781821180656
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21844,282,1.22 [0.99-1.50],0.0572720488222684
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21610,48,1.26 [0.77-2.07],0.3602721461066425
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24692,3130,1.16 [1.09-1.24],2.83962437720325e-06
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21759,197,1.12 [0.87-1.44],0.383911690045463
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22096,534,1.17 [1.00-1.36],0.0493246303528369
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27033,361,1.23 [1.03-1.48],0.0259554413655693
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,26849,177,1.43 [1.11-1.83],0.0048207473005797
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21664,102,0.93 [0.64-1.34],0.6876846138663437
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",21617,55,1.42 [0.91-2.21],0.1266644047288369
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26256,2308,1.11 [1.03-1.19],0.0075743097762523
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21767,205,1.06 [0.82-1.37],0.6484623094182187
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21774,212,1.48 [1.18-1.86],0.0006819294038152
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22092,530,1.22 [1.05-1.42],0.0111222518822819
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21654,92,1.20 [0.83-1.73],0.3353864630811397
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,26839,167,1.38 [1.07-1.79],0.0138052143500886
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22189,627,0.96 [0.83-1.11],0.5647927749962596
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22126,564,1.09 [0.94-1.27],0.2393517882190183
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24358,70,1.08 [0.70-1.65],0.7291178954115263
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26236,4674,1.15 [1.09-1.21],1.2707478974186554e-07
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24025,77,0.97 [0.64-1.47],0.8818374801409024
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24037,89,1.01 [0.69-1.48],0.9588434643349304
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26943,2067,1.00 [0.93-1.08],0.9630106971496074
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26947,2065,1.00 [0.93-1.08],0.9686939211064964
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24029,81,1.19 [0.81-1.75],0.3758740470386824
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,26731,1569,1.06 [0.97-1.16],0.1911008562430776
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23079,1517,1.10 [1.00-1.20],0.0517592946612375
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27123,180,1.18 [0.91-1.54],0.2191208229147991
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26244,55,1.32 [0.83-2.09],0.2384481383900623
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25289,127,0.96 [0.69-1.33],0.8029620312266648
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25356,194,1.22 [0.95-1.57],0.1184480310138543
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21824,262,1.40 [1.14-1.72],0.0012464770195929
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25326,138,1.14 [0.85-1.54],0.3814939875245164
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1682,45,0.93 [0.53-1.62],0.7913964417472261
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1798,185,1.24 [0.95-1.60],0.108091756395247
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25213,25,1.62 [0.84-3.11],0.1484180291632113
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1668,32,1.26 [0.68-2.35],0.4584785271387536
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26655,1467,1.28 [1.17-1.40],1.123713614272179e-07
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,26529,340,0.92 [0.75-1.12],0.3962872918114741
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,24763,475,1.09 [0.92-1.28],0.3113929067744007
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22288,726,1.07 [0.94-1.23],0.2988317045837632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27036,232,1.12 [0.89-1.41],0.3492092473546329
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26147,51,0.93 [0.55-1.55],0.770277380767598
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,25609,865,1.25 [1.11-1.40],0.000225120134587
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26191,95,0.75 [0.51-1.11],0.1460487822677827
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26129,33,1.53 [0.86-2.69],0.1451416336987778
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26244,148,1.43 [1.09-1.87],0.0104769291431003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17629,1458,1.07 [0.98-1.18],0.1427793641481944
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,AV-block,23757,234,1.14 [0.90-1.43],0.2675823539468652
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27096,303,0.85 [0.69-1.06],0.1420157671142617
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiac arrest,16299,128,1.66 [1.26-2.19],0.0003391543883067
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23657,134,0.88 [0.63-1.21],0.4280200404080188
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",23602,79,1.03 [0.69-1.55],0.8758674440458736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27133,34,1.48 [0.83-2.62],0.1847379014325108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,24242,719,1.11 [0.97-1.27],0.1197712011545587
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26231,1497,1.20 [1.09-1.31],9.360431797087932e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24376,7174,1.11 [1.06-1.15],2.146439710291744e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25631,247,1.16 [0.92-1.45],0.2028654958254301
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Endocarditis,23585,62,1.36 [0.89-2.08],0.159837608753493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27038,848,1.16 [1.03-1.31],0.0182158904809504
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,24997,6078,1.11 [1.06-1.16],1.2567587475329598e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25009,6090,1.11 [1.06-1.16],9.71714879870559e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27025,42,0.76 [0.42-1.38],0.3682292459963801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19083,164,1.09 [0.82-1.45],0.5699651367001632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19021,102,1.71 [1.24-2.35],0.0011059545008243
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,26997,1094,0.98 [0.88-1.09],0.7002829042143106
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26384,97,1.33 [0.95-1.86],0.0956950662554914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26418,1674,1.21 [1.11-1.31],1.429926499157433e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26824,453,1.06 [0.89-1.25],0.5248889708383928
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Left bundle-branch block,23819,296,1.15 [0.93-1.41],0.1938066142995282
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26915,600,1.19 [1.04-1.37],0.0148836134120969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25230,486,1.20 [1.03-1.41],0.0210106043538526
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27113,85,1.58 [1.13-2.20],0.0077444517347266
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27132,242,1.16 [0.93-1.46],0.1905160150590326
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Oesophageal varices,25421,37,1.21 [0.68-2.14],0.522634983968804
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other aneurysm,26151,55,0.78 [0.46-1.29],0.3297830674821501
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,23880,357,1.08 [0.90-1.31],0.4084962809740656
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26159,63,1.45 [0.96-2.20],0.0811948471114236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26285,189,1.05 [0.81-1.36],0.7209886186599239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,23682,159,1.07 [0.80-1.42],0.6640389558628972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other disorders of veins,25479,95,1.10 [0.76-1.59],0.6114352381610886
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25428,44,1.41 [0.86-2.33],0.1771359070359556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,25887,38,0.86 [0.47-1.58],0.6219000511311108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,25542,158,0.98 [0.73-1.31],0.8720349756604908
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24320,797,1.10 [0.97-1.24],0.1531583339051016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,25946,43,1.04 [0.60-1.80],0.9011142202438892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26586,490,0.98 [0.83-1.16],0.8488668528945035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26570,322,1.08 [0.89-1.32],0.4361122905148511
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26393,544,0.93 [0.79-1.09],0.3525238981085359
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16460,289,1.12 [0.91-1.39],0.2717204691834078
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26350,267,1.11 [0.89-1.38],0.352148701528248
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25708,324,1.17 [0.96-1.42],0.1142688397332026
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26682,434,1.18 [1.00-1.40],0.0527323151973299
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27062,591,1.14 [0.98-1.31],0.0851526692542591
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Right bundle-branch block,23744,221,1.04 [0.81-1.32],0.7645873532976195
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26563,315,1.10 [0.89-1.34],0.3779090446649689
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26010,161,1.12 [0.84-1.48],0.444396088459698
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26817,530,1.09 [0.93-1.27],0.2901935880530782
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26791,576,1.07 [0.92-1.24],0.3662684851917643
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26351,70,1.07 [0.69-1.64],0.772890078711625
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26142,46,0.80 [0.46-1.39],0.4292666061706642
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26588,217,1.09 [0.86-1.39],0.4768460510768493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26512,197,1.40 [1.11-1.78],0.0051456032244396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,25842,458,1.00 [0.84-1.18],0.9648709321221206
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26107,97,0.78 [0.53-1.14],0.1964950499068686
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26924,691,1.14 [0.99-1.30],0.0605799787750844
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27093,215,0.96 [0.75-1.24],0.7802368478654467
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24081,1831,1.09 [1.00-1.19],0.0383421129373097
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,26525,4275,1.09 [1.03-1.15],0.0015054957409518
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27061,254,0.99 [0.79-1.24],0.9224556227751964
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24199,1949,1.11 [1.02-1.20],0.0140911210895652
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22344,94,1.11 [0.76-1.61],0.5876886306850373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,26728,1188,1.23 [1.11-1.37],9.058160326464509e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23618,1368,1.18 [1.07-1.30],0.0007321240001401
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Vascular dementia,26634,100,0.80 [0.55-1.17],0.2443554012146969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Alzheimer disease,27137,356,0.94 [0.78-1.15],0.5599107846221982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",18500,58,1.30 [0.83-2.05],0.2546779118217863
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Bell's palsy,24997,85,1.03 [0.70-1.53],0.871971059036635
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25530,618,1.07 [0.93-1.23],0.3657749563209703
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral cysts,26740,220,1.12 [0.88-1.42],0.342530646669524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27064,274,0.93 [0.74-1.16],0.5229962914909791
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,26654,39,0.75 [0.41-1.38],0.3525129649675723
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27123,45,1.49 [0.91-2.42],0.1099859745415413
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",26573,53,1.02 [0.62-1.68],0.9301798260474674
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,25662,281,1.06 [0.86-1.32],0.581160877454151
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26720,1339,1.07 [0.97-1.18],0.2067256676906662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27089,508,1.02 [0.87-1.20],0.7939474734945132
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26506,2883,0.96 [0.90-1.03],0.2618727800086876
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Generalized epilepsy,26767,46,1.29 [0.78-2.14],0.3294777193594942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,27008,218,1.00 [0.78-1.28],0.9970367529044644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hydrocephalus,26587,67,1.30 [0.86-1.96],0.2216796740344158
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27118,75,1.53 [1.06-2.21],0.0232506367950598
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25034,122,0.77 [0.55-1.09],0.1387822600325159
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,24976,64,1.58 [1.06-2.36],0.0240870913815294
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Memory loss,26510,96,1.07 [0.74-1.54],0.7295598462271689
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,25885,504,1.15 [0.99-1.35],0.0763658051613188
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27022,453,1.13 [0.95-1.33],0.1588407840092586
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Motor neuron disease,18586,119,0.96 [0.68-1.34],0.8067274267158503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,26923,142,1.17 [0.87-1.57],0.2984691547327953
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26289,1377,1.06 [0.96-1.17],0.2313154141222686
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,25533,3770,1.04 [0.98-1.11],0.1512569499449726
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,26774,159,0.90 [0.67-1.21],0.4847022551569175
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25335,423,1.09 [0.92-1.30],0.3052121818908455
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27081,230,1.28 [1.02-1.60],0.0296827958790796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21839,660,0.99 [0.86-1.14],0.9041041358570396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,26589,69,1.19 [0.78-1.81],0.4155192426706418
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other disorders of nervous system,26642,122,0.92 [0.66-1.28],0.6126477504076024
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,26765,184,1.05 [0.80-1.37],0.7297667425244999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25007,95,1.01 [0.70-1.47],0.9483493815221364
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other headache syndromes,25454,73,1.30 [0.87-1.95],0.1993595983472319
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,27020,500,1.16 [0.99-1.36],0.0664585081930272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,25783,402,0.95 [0.79-1.14],0.55197445002567
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Parkinson's disease,27113,306,0.99 [0.81-1.22],0.9476319082286638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,26603,83,1.22 [0.83-1.79],0.3021350419572647
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Restless leg syndrome,27136,103,1.04 [0.73-1.48],0.8324594270537382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,26959,318,0.90 [0.73-1.11],0.3256716269538699
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Small fibre neuropathy,26891,40,1.49 [0.90-2.46],0.1178552056238539
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27127,147,0.86 [0.63-1.17],0.3331306841083939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,24977,65,1.03 [0.66-1.61],0.8872386654108407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27137,360,0.94 [0.77-1.14],0.5210632202295962
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),26591,97,0.78 [0.53-1.15],0.2152723393564867
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,26559,109,0.97 [0.68-1.37],0.8463792354434533
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,26680,479,0.97 [0.82-1.15],0.7149023802371985
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26992,172,1.27 [0.98-1.66],0.0727898482642666
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26033,61,1.46 [0.96-2.21],0.0731929516643606
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26026,54,1.06 [0.65-1.74],0.8123938290578259
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27020,54,1.37 [0.87-2.16],0.1762784741854927
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,26851,164,0.92 [0.69-1.23],0.5785179391394388
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1675,38,1.22 [0.69-2.15],0.503340234209287
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2016,68,0.91 [0.59-1.43],0.6930262377474997
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,26538,88,0.94 [0.63-1.39],0.7445254028593172
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26960,1056,1.09 [0.98-1.22],0.1240770075560969
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26718,746,1.00 [0.87-1.14],0.9833228503723732
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26265,293,0.97 [0.78-1.20],0.7866061636744833
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27044,843,1.02 [0.90-1.16],0.7193447952864778
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27120,68,1.25 [0.82-1.89],0.2974139778703437
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,26968,767,1.00 [0.87-1.14],0.9683487673128116
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27092,405,0.97 [0.81-1.16],0.7237070358126692
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27043,200,0.88 [0.68-1.14],0.3398553064396215
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26012,40,0.70 [0.38-1.30],0.2556634076418953
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26019,47,1.28 [0.79-2.08],0.3171533556375233
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26037,65,0.98 [0.62-1.54],0.9172916379566304
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27049,714,1.00 [0.88-1.15],0.9524933737106324
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,26516,181,0.98 [0.75-1.29],0.8952161828489543
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26266,65,1.08 [0.70-1.68],0.7266412019399424
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,26789,102,1.01 [0.70-1.44],0.9736185601607124
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,26996,309,0.96 [0.78-1.19],0.7300170656948944
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26410,209,1.02 [0.79-1.30],0.8992935060844638
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,26974,131,0.77 [0.55-1.07],0.1231702064729765
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26803,468,1.02 [0.86-1.21],0.8129801999936714
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,26601,151,0.95 [0.70-1.28],0.7350142668317663
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25347,2470,1.04 [0.97-1.12],0.274149945730905
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,26956,269,0.96 [0.77-1.20],0.741112540439428
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27111,153,1.01 [0.75-1.35],0.9639580265162851
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26356,384,1.05 [0.88-1.27],0.5750067321033547
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,26750,63,1.00 [0.63-1.58],0.9917697583017572
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27105,53,1.40 [0.89-2.19],0.1493818145808465
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26065,93,1.03 [0.71-1.50],0.8708770816543865
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26121,149,1.01 [0.75-1.36],0.9504340670893344
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26010,106,1.20 [0.86-1.68],0.2762320681143466
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26272,71,1.30 [0.87-1.94],0.2035740312299848
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",25961,57,0.66 [0.39-1.11],0.1145948023922466
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,26452,117,0.90 [0.64-1.27],0.5575203230936625
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",26515,180,1.01 [0.77-1.33],0.93593383521089
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26103,131,1.26 [0.93-1.70],0.1358455492670311
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26002,98,1.30 [0.93-1.83],0.1290213949224192
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,25979,75,1.45 [1.00-2.10],0.0511026502327178
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,24958,2081,1.00 [0.93-1.09],0.9037508937287148
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26055,83,1.10 [0.75-1.63],0.6247080570397532
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26873,423,1.01 [0.85-1.20],0.926693811674842
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,26496,46,1.13 [0.67-1.91],0.6391663599196522
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),26616,166,1.19 [0.91-1.56],0.2094232400355777
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,26898,113,0.93 [0.66-1.31],0.6779638593387955
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27089,116,1.12 [0.81-1.56],0.4824137642885751
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27011,139,1.10 [0.81-1.49],0.5312766477058959
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,26850,65,1.12 [0.72-1.74],0.607573153512946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,26851,66,1.00 [0.64-1.56],0.9915214017770856
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27033,813,1.01 [0.89-1.15],0.8360654156016445
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,26779,559,1.05 [0.90-1.22],0.5689877340625739
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26343,123,0.97 [0.69-1.35],0.8382521893659287
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26306,86,0.87 [0.58-1.30],0.4914068947931465
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute pharyngitis,26870,83,1.03 [0.69-1.53],0.8930198966908606
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27014,227,0.86 [0.67-1.10],0.221981473911756
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,26851,64,0.90 [0.56-1.43],0.649454610066778
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza,25436,126,1.23 [0.91-1.68],0.1841582553714393
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25434,124,1.25 [0.92-1.71],0.1531747907330925
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19286,124,1.21 [0.88-1.65],0.2377232149109283
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic rhinitis,26987,283,1.09 [0.88-1.35],0.428884251484387
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20999,2023,1.05 [0.97-1.13],0.263455879503096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21159,1997,1.05 [0.97-1.14],0.2050468817391964
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),26724,120,1.29 [0.95-1.77],0.1059905578067935
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25375,65,1.57 [1.05-2.34],0.027980802982583
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bronchiectasis,23494,410,1.20 [1.01-1.43],0.0337072577151034
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23154,70,1.15 [0.75-1.74],0.5248416958416787
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26000,2916,1.06 [1.00-1.14],0.0639124810262469
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",25863,62,0.83 [0.51-1.34],0.4442477507795643
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,25944,143,1.22 [0.92-1.63],0.1693864825258588
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26967,1049,1.10 [0.98-1.23],0.0914991595275884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,25875,74,1.16 [0.77-1.74],0.4781839280714568
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25077,5100,1.10 [1.05-1.16],0.000140642538433
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26134,333,1.09 [0.90-1.33],0.3888434570881753
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,26230,312,1.09 [0.88-1.34],0.4367186794634626
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Emphysema,23353,269,1.36 [1.11-1.67],0.0034854560683013
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25536,227,1.16 [0.92-1.47],0.2010369231995357
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26944,1634,1.11 [1.02-1.22],0.0154851833867486
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,25573,264,1.19 [0.96-1.48],0.1080380672955224
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Later onset COPD,26240,737,1.12 [0.98-1.27],0.0868414900296764
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27130,222,0.98 [0.77-1.25],0.8766271816463311
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,25866,65,1.12 [0.72-1.74],0.6071925140439578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26916,908,1.10 [0.98-1.24],0.1082197349377006
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,26950,1731,1.10 [1.01-1.20],0.0249436230340445
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26582,781,1.14 [1.01-1.30],0.0392908863264328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other pleural conditions,25255,36,0.62 [0.32-1.20],0.1568870634699082
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27058,337,1.10 [0.91-1.34],0.3355598679145954
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27050,1169,1.11 [1.00-1.24],0.0404705582658391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,26058,839,1.10 [0.98-1.25],0.1181253350020323
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural plaque,25263,44,1.65 [1.02-2.67],0.0409763412900134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26717,1407,1.09 [0.99-1.20],0.0643112806521475
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27103,195,0.91 [0.70-1.19],0.5119811369301543
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumothorax,25307,88,1.24 [0.86-1.80],0.2431775603590598
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pollen allergy,27106,237,1.12 [0.89-1.41],0.3438178863692432
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pulmonary oedema,26782,61,0.87 [0.54-1.40],0.557076252388859
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19214,52,1.36 [0.84-2.19],0.2135212788183955
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26892,884,1.09 [0.97-1.23],0.1407304616830472
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26084,283,1.09 [0.88-1.35],0.4094554944965036
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Viral pneumonia,25516,206,1.05 [0.81-1.35],0.7130931985638256
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",26735,164,0.99 [0.75-1.32],0.9512564669272604
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13112,106,1.12 [0.79-1.58],0.5346745820166681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19335,37,0.89 [0.48-1.65],0.7119865973120865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,26951,146,0.81 [0.59-1.11],0.1855182060177314
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute gastritis,20372,91,0.83 [0.56-1.23],0.3580444335145405
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,24856,160,1.18 [0.90-1.56],0.2361878125014638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute peritonitis,26572,87,1.06 [0.72-1.56],0.7643506887094935
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26264,33,1.03 [0.55-1.94],0.9232843522828378
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Barrett oesophagus,20611,330,1.04 [0.85-1.26],0.7159992545070841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",24774,78,1.76 [1.25-2.49],0.001189582123551
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",26711,78,1.75 [1.24-2.46],0.0015220377531274
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,24878,182,1.07 [0.82-1.40],0.6211618416662448
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,25870,1174,1.06 [0.95-1.17],0.3067709264344763
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,20618,337,1.16 [0.96-1.40],0.1357928573444202
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic pancreatitis,24736,40,0.77 [0.42-1.41],0.4037579548557181
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27054,71,1.14 [0.75-1.73],0.5500481344127048
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,25607,149,1.06 [0.79-1.43],0.6767265016924227
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Collagenous colitis,25251,111,0.89 [0.63-1.27],0.530299195318066
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,26999,149,1.13 [0.85-1.51],0.4025521220416493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,26795,1714,1.06 [0.97-1.15],0.1948764141202822
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,25234,94,1.07 [0.74-1.54],0.7264746768838817
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26781,70,1.01 [0.66-1.56],0.9651972948520336
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25237,97,1.06 [0.73-1.52],0.7712324922748223
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,26332,228,1.03 [0.81-1.31],0.7930476573775662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25530,2449,1.07 [0.99-1.14],0.0849989989862571
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,26994,189,0.97 [0.74-1.26],0.8031836606456344
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,27035,804,1.16 [1.03-1.31],0.0180236332713828
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24855,4574,1.02 [0.96-1.07],0.5664812905126708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26677,573,1.07 [0.92-1.24],0.3737713205548242
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27013,528,0.97 [0.83-1.14],0.719355357110795
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26217,113,0.93 [0.66-1.32],0.6878417067202504
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26069,65,1.19 [0.77-1.84],0.4309926222471747
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26841,1383,1.00 [0.90-1.10],0.9642658464697648
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of tongue,26078,110,0.78 [0.55-1.13],0.1876209459258339
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26276,1580,1.10 [1.01-1.21],0.0312777452819424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22475,3177,1.05 [0.98-1.11],0.1682849351599917
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,20408,127,1.13 [0.82-1.54],0.454232118673371
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27084,107,0.99 [0.70-1.41],0.9640808636204634
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27034,60,1.40 [0.91-2.16],0.1252167220348207
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26323,92,1.30 [0.91-1.85],0.1551714868861181
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19409,111,1.30 [0.95-1.79],0.1046718424212392
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,20936,655,1.02 [0.89-1.17],0.7904625027989332
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,20626,345,0.99 [0.82-1.21],0.9359507468626836
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23046,2765,1.03 [0.96-1.10],0.3908670349343978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20747,466,1.04 [0.88-1.23],0.6513061478686402
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21214,8369,1.04 [1.00-1.08],0.0423924483407602
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,26585,1127,1.02 [0.91-1.13],0.7716034251922493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26167,63,1.18 [0.76-1.83],0.4711722282781833
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20263,1255,1.12 [1.01-1.24],0.0267137841420312
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26272,41,1.03 [0.58-1.82],0.9177483574151712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,25958,2877,1.04 [0.97-1.11],0.2503337680430906
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,27044,55,1.50 [0.96-2.33],0.0723663802014921
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impaction of intestines,19362,64,1.62 [1.10-2.36],0.0133203506898927
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,23243,162,0.83 [0.62-1.11],0.210282346006855
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19399,101,0.85 [0.59-1.24],0.3981311222037741
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25629,171,0.99 [0.75-1.30],0.9288551967648396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20104,806,1.03 [0.90-1.17],0.6859381377341254
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27121,355,1.23 [1.03-1.48],0.025281217324668
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,25952,812,1.12 [0.99-1.27],0.0690595949891128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26236,1096,1.09 [0.98-1.22],0.1043956479854164
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20438,157,1.23 [0.93-1.61],0.1422489309222604
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,20850,569,1.00 [0.86-1.17],0.9788368726660792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27090,154,1.24 [0.94-1.64],0.1211780870034578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23140,59,1.18 [0.75-1.85],0.4715284794143017
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20563,1265,1.05 [0.95-1.16],0.3212616717392964
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24995,299,1.17 [0.96-1.44],0.1226756154716098
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,24888,192,1.16 [0.90-1.50],0.2446611834989563
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,20879,1581,0.96 [0.87-1.05],0.3778481434477733
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,24982,5684,1.02 [0.97-1.07],0.3887905033720147
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26070,228,1.17 [0.93-1.48],0.1748713200507248
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,26907,676,1.15 [1.00-1.31],0.048837310858648
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20849,568,1.06 [0.91-1.23],0.4517603199288812
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of pancreas,24853,157,1.19 [0.90-1.56],0.2301680015983684
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26949,464,0.94 [0.79-1.12],0.493923141292805
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21351,1070,0.99 [0.88-1.10],0.7993651620639558
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26601,1143,1.02 [0.92-1.14],0.7026970513329343
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26290,186,1.03 [0.79-1.34],0.8265632459588079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21065,1767,1.06 [0.97-1.15],0.196146160327291
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22387,2106,1.03 [0.96-1.12],0.4097575712358161
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26328,97,1.15 [0.80-1.64],0.4514997235967224
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26105,965,1.08 [0.96-1.21],0.1845498927092651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19624,326,1.15 [0.95-1.39],0.1616789716962393
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27023,68,1.37 [0.91-2.06],0.1295291458819229
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19787,489,1.00 [0.85-1.18],0.9866778145848764
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25585,127,0.78 [0.56-1.09],0.1512569837176017
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27128,68,0.83 [0.52-1.31],0.4232061729282687
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26104,124,1.02 [0.74-1.41],0.9002436221653681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Toxic colitis,25206,66,0.94 [0.60-1.47],0.7750944361046258
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20514,233,1.04 [0.82-1.32],0.7312467056176195
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,25304,164,1.05 [0.79-1.39],0.735428905502738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25275,135,1.02 [0.75-1.39],0.8996359097706541
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,23252,171,0.77 [0.58-1.03],0.0768322401308079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19489,191,0.96 [0.74-1.25],0.777589864462215
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,23329,248,0.99 [0.78-1.24],0.9042491565980152
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Volvulus,19383,85,0.67 [0.44-1.03],0.0688265953364976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27051,258,1.19 [0.96-1.47],0.1158944896512128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,26820,74,1.10 [0.73-1.67],0.6405337480217834
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25087,219,1.09 [0.86-1.39],0.458261690465695
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26613,622,1.04 [0.90-1.20],0.6241822550659802
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26132,141,1.35 [1.01-1.79],0.0420442831060955
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25196,328,1.00 [0.81-1.22],0.971894980874533
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,26825,277,1.31 [1.06-1.60],0.0106895666293856
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27027,479,1.19 [1.02-1.40],0.0319306900352377
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,26599,51,1.38 [0.87-2.21],0.1710345093943612
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25544,3142,1.05 [0.98-1.12],0.1352137965828665
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26685,472,0.95 [0.80-1.12],0.5186075074155462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26542,329,0.96 [0.78-1.17],0.6725806335332389
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26825,834,1.07 [0.95-1.21],0.2684560051100736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27115,75,0.91 [0.60-1.39],0.6678688344341503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,24958,90,0.83 [0.56-1.24],0.3735056500950641
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26258,45,1.36 [0.82-2.25],0.22783735520237
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,26810,262,1.29 [1.05-1.60],0.01637692593578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25282,414,1.06 [0.89-1.26],0.5421492687094454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,24914,46,0.90 [0.52-1.54],0.6904275024164976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27032,83,0.80 [0.53-1.22],0.2989084703457586
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26148,157,1.36 [1.04-1.78],0.0227725463469211
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26910,164,0.72 [0.53-0.97],0.0285495544306629
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,26602,54,0.82 [0.49-1.37],0.4517810367323341
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,24931,63,1.35 [0.89-2.06],0.155917565514256
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26448,1580,1.03 [0.94-1.13],0.5417552434743114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25316,448,1.07 [0.90-1.26],0.4584307517496713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,24918,50,0.94 [0.56-1.57],0.8036051426177445
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27051,305,0.86 [0.70-1.07],0.1741884237834398
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,26630,82,0.99 [0.66-1.48],0.964259751517712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26980,234,0.86 [0.68-1.10],0.2372072347314271
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27087,294,1.16 [0.95-1.42],0.155510406516562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25028,160,1.21 [0.92-1.59],0.1766910275933007
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25128,260,0.89 [0.71-1.12],0.3183293344194346
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27073,280,1.14 [0.93-1.41],0.2089345600577548
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25064,196,1.20 [0.93-1.54],0.160379082103098
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27100,151,0.83 [0.61-1.13],0.2345340680122743
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23152,127,1.40 [1.04-1.88],0.0269514060764425
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,24662,6332,1.02 [0.97-1.06],0.4632872303845544
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23274,4944,1.03 [0.98-1.09],0.2239996759984006
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23100,75,1.04 [0.68-1.58],0.8565348339570472
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23270,152,1.24 [0.94-1.64],0.1287245650589425
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23326,208,1.00 [0.78-1.29],0.9992449686911687
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,26848,113,0.98 [0.70-1.38],0.9156033656069726
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23232,114,0.94 [0.67-1.33],0.7223088431444322
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19693,1363,1.02 [0.92-1.12],0.725204829106588
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",26985,220,1.13 [0.89-1.43],0.318028180639936
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23725,607,1.07 [0.93-1.24],0.3388510146263102
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22820,8037,1.02 [0.98-1.06],0.3938627051243675
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24310,137,1.00 [0.74-1.37],0.9853914481325732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23156,131,1.08 [0.79-1.48],0.6266278463424022
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23709,684,1.22 [1.07-1.39],0.003270090652305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26125,3007,1.04 [0.98-1.12],0.192914410158367
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23198,173,0.87 [0.65-1.16],0.3407708505907156
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23396,371,1.24 [1.03-1.48],0.019661222360846
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23192,167,1.41 [1.10-1.83],0.0078493696870096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26207,102,0.89 [0.62-1.29],0.5523230346790255
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20189,1859,0.98 [0.90-1.07],0.6467415723758743
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18552,222,1.48 [1.19-1.84],0.0004017776898112
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27125,219,1.50 [1.20-1.87],0.0003729468217827
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18427,97,1.48 [1.07-2.04],0.0182617427792937
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18904,574,0.95 [0.81-1.11],0.5004230290689078
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23358,333,0.96 [0.78-1.17],0.6796747193221315
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18956,626,0.94 [0.81-1.09],0.3879489935496286
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23186,68,1.19 [0.79-1.81],0.4094741040761056
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23825,707,1.08 [0.95-1.24],0.2395122066301722
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23453,335,1.14 [0.94-1.38],0.1842068675157853
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18914,584,0.93 [0.80-1.09],0.3785873650782876
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23115,90,1.52 [1.08-2.14],0.0174247613537581
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23094,69,1.08 [0.70-1.67],0.7215414158519291
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24219,46,1.15 [0.68-1.93],0.6007984418965069
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26660,2487,1.00 [0.93-1.07],0.9700363695146708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25970,1797,0.99 [0.91-1.08],0.8842172395130906
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26937,604,1.19 [1.04-1.38],0.0145859864877461
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21341,3011,1.06 [0.99-1.13],0.0823645058058809
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18402,72,1.26 [0.84-1.89],0.2545353495189818
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23126,101,1.29 [0.92-1.81],0.1470949541913879
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18373,43,0.86 [0.49-1.52],0.6027528088362469
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18531,201,0.97 [0.75-1.26],0.8244201517793164
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24461,288,0.95 [0.76-1.18],0.6411245927685418
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,24756,583,1.02 [0.88-1.19],0.769365056695159
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27106,112,1.45 [1.06-1.97],0.0188553216157562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25140,2022,1.06 [0.98-1.15],0.171473830348138
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23156,131,1.00 [0.73-1.38],0.9820774635749068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18560,230,0.83 [0.65-1.07],0.1480364819963242
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23932,814,1.00 [0.88-1.13],0.9631779690422548
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20845,2515,1.00 [0.93-1.07],0.9913845415846698
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26230,125,0.88 [0.63-1.22],0.4419190329932962
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27117,74,1.19 [0.79-1.79],0.4044843564957672
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23106,81,0.83 [0.55-1.27],0.4006692806966816
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24484,1459,1.08 [0.98-1.18],0.1181428714857116
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23106,81,1.16 [0.78-1.72],0.4609091527844664
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20309,1979,1.05 [0.97-1.14],0.2151172002853265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24307,134,0.92 [0.67-1.27],0.6294882897428001
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23089,64,1.13 [0.72-1.76],0.5945005239616894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23311,193,0.90 [0.69-1.18],0.4630354742268432
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23609,584,1.07 [0.92-1.24],0.3688144552492798
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26603,498,1.19 [1.02-1.40],0.0243724010906905
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23762,644,1.06 [0.92-1.22],0.4103577642854573
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26952,585,1.21 [1.05-1.40],0.0100858244414069
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27107,69,1.31 [0.87-1.97],0.1900653658400651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23251,226,1.12 [0.89-1.42],0.3304389038213922
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20821,901,1.04 [0.92-1.17],0.5184860744005566
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23690,665,1.01 [0.88-1.16],0.9041763150810562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23148,123,0.95 [0.68-1.33],0.772724420015708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18406,76,0.89 [0.58-1.37],0.5974536670008661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20960,2630,1.09 [1.02-1.17],0.010376548321272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19164,834,1.07 [0.94-1.21],0.3105113351444259
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26398,293,1.25 [1.02-1.52],0.0289908769445645
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27079,85,1.26 [0.87-1.82],0.2275332136774313
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",24859,53,0.94 [0.56-1.56],0.8082669435990265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18404,74,1.19 [0.80-1.79],0.3899711102706974
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23231,113,1.07 [0.77-1.50],0.6725650974714146
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18937,607,1.20 [1.04-1.38],0.0129975289790296
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23359,334,0.95 [0.78-1.16],0.6160570524360096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23400,282,1.22 [0.99-1.50],0.0578952701054597
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23400,282,0.96 [0.78-1.20],0.7451782459304933
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20969,87,1.12 [0.76-1.63],0.5682509708349313
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27114,76,1.17 [0.78-1.75],0.4444707951883807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23665,640,1.01 [0.87-1.16],0.92108601098994
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],26265,160,1.17 [0.89-1.54],0.2646208255997799
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25821,2796,1.08 [1.01-1.16],0.0218794192078982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23182,157,0.85 [0.63-1.15],0.298930311952122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23697,579,1.08 [0.93-1.25],0.3115152861717234
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,25436,258,0.88 [0.70-1.11],0.2925911311788838
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23393,275,1.21 [0.99-1.49],0.066092375833412
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24875,1757,1.00 [0.91-1.09],0.9587798555064276
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24314,1196,1.02 [0.92-1.13],0.679524592411894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23088,63,1.15 [0.73-1.79],0.553136400180096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26323,218,0.96 [0.75-1.23],0.7461126969590999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23226,201,1.20 [0.94-1.54],0.1393113310982198
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23153,128,0.89 [0.64-1.24],0.4989906414445865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18384,54,1.44 [0.93-2.23],0.1017143892709623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26070,1240,1.25 [1.14-1.38],6.595058848692365e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20292,100,1.03 [0.71-1.48],0.8810723925456823
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26439,112,0.92 [0.65-1.31],0.6399009363579364
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26976,233,1.21 [0.96-1.51],0.1075595171155152
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,26770,27,0.52 [0.24-1.12],0.0958068560649738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26307,1477,1.21 [1.10-1.32],6.324639353551983e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,26962,79,1.73 [1.23-2.45],0.0017428297383355
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,26929,242,1.09 [0.87-1.37],0.4440774924666752
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,23944,254,0.90 [0.71-1.13],0.3594190710908782
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dialysis,24883,53,1.71 [1.13-2.60],0.0112895604850898
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26666,339,1.05 [0.86-1.27],0.6449534111942425
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,20368,176,0.99 [0.75-1.30],0.9191717701008608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20583,391,0.82 [0.68-1.00],0.0449043428039828
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21189,997,0.96 [0.86-1.08],0.5139964894498681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21121,5020,1.06 [1.01-1.11],0.0285299611660139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,26949,66,1.44 [0.96-2.16],0.0779797028833361
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,24708,207,0.94 [0.72-1.21],0.6120192845895296
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26597,393,0.83 [0.69-1.00],0.0540164980602792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Irregular menses,26670,126,0.68 [0.48-0.96],0.028615850909731
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20493,301,0.94 [0.75-1.16],0.5472354933093402
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23767,77,1.06 [0.70-1.59],0.7813824140828971
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22629,2437,0.97 [0.90-1.05],0.4757758026979508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20332,140,1.15 [0.85-1.55],0.3588418353050441
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27122,65,1.39 [0.92-2.09],0.1200144248690789
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27126,73,0.73 [0.46-1.14],0.1642010410569811
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25906,2216,1.02 [0.95-1.11],0.5357505032884553
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24154,464,0.98 [0.83-1.17],0.8594569040241697
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26444,117,1.10 [0.79-1.52],0.5836757241193584
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27075,388,1.21 [1.02-1.44],0.0332704857753354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27076,91,1.05 [0.72-1.53],0.8028691224464508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25595,1905,1.05 [0.97-1.14],0.2275734853097126
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26402,198,0.92 [0.71-1.20],0.5310727389700794
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20346,154,1.13 [0.85-1.50],0.4136229421652513
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20557,365,0.91 [0.75-1.11],0.3672167201970039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20300,108,1.16 [0.83-1.63],0.383145438385173
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20398,206,1.19 [0.94-1.53],0.1537440663516424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24761,260,0.99 [0.79-1.25],0.9493174300418454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,26812,125,1.28 [0.94-1.74],0.1117015239997113
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20501,309,1.05 [0.86-1.29],0.6135939129529846
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20297,105,0.81 [0.56-1.17],0.2675118845583301
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20826,634,0.94 [0.81-1.09],0.4224620243682739
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20351,159,1.08 [0.81-1.43],0.5925718561881943
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20778,586,1.03 [0.88-1.19],0.7312675010095594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,26922,39,0.96 [0.53-1.74],0.8984921707752254
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26944,2443,1.16 [1.08-1.24],6.521338134749987e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",24661,160,1.25 [0.95-1.64],0.1110747607474552
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24934,104,0.94 [0.65-1.35],0.722622217448869
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26776,33,1.52 [0.86-2.70],0.1470893046388742
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23836,146,1.15 [0.86-1.53],0.3516762183203272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27009,266,1.18 [0.96-1.47],0.120925811533206
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20328,136,1.22 [0.90-1.65],0.1948060802045434
